TransMedics Group, Inc.
Returns on Capital
| Fiscal Year | ROE | ROI | ROA |
|---|---|---|---|
| FY2021 | -65.2% | -42.9% | -32.8% |
| FY2022 | -19.3% | -14.7% | -13.1% |
| FY2023 | -18.2% | -18.2% | -3.5% |
| FY2024 | 15.5% | 15.5% | 4.4% |
| FY2025 | 40.2% | 40.2% | 17.8% |
Returns on Capital
| Fiscal Year | ROE | ROI | ROA |
|---|---|---|---|
| FY2021 | -65.2% | -42.9% | -32.8% |
| FY2022 | -19.3% | -14.7% | -13.1% |
| FY2023 | -18.2% | -18.2% | -3.5% |
| FY2024 | 15.5% | 15.5% | 4.4% |
| FY2025 | 40.2% | 40.2% | 17.8% |